Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 976-981 , August 1995

Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents

  • Theodore P. Ciaraldi

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Theodore P. Ciaraldi, PhD, Division of Endocrinology 0673, University of California, San Diego, La Jolla, CA 92093.
    • Medical Research Service, San Diego Veterans Affairs Medical Center, San Diego, LaJolla, CA, USA
    • Department of Medicine, University of California, San Diego, LaJolla, CA, USA
    • ,
  • Kathleen Huber-Knudsen

      Affiliations

    • Medical Research Service, San Diego Veterans Affairs Medical Center, San Diego, LaJolla, CA, USA
    • Department of Medicine, University of California, San Diego, LaJolla, CA, USA
    • ,
  • Matt Hickman

      Affiliations

    • Medical Research Service, San Diego Veterans Affairs Medical Center, San Diego, LaJolla, CA, USA
    • Department of Medicine, University of California, San Diego, LaJolla, CA, USA
    • ,
  • Jerrold M. Olefsky

      Affiliations

    • Medical Research Service, San Diego Veterans Affairs Medical Center, San Diego, LaJolla, CA, USA
    • Department of Medicine, University of California, San Diego, LaJolla, CA, USA

Received 11 April 1994 ,Accepted 13 December 1994.

References 

  1. Defronzo RA. Lilly Lecture. The triumvirate: β-Cell, muscle, liver. In: A collusion responsible for NIDDM. ed 6. Diabetes. 37:1988;p. 667–687
  2. Baron AD, Brechtel G, Wallace P, et al.  Rates and tissue sites of non—insulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 1988;255:E769–E774
  3. Baron AD, Lasko M, Brechtel G, et al.  Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in non—insulin-dependent diabetic subjects. J Clin Invest. 1991;87:1186–1194
  4. Garvey WT. Glucose transport and NIDDM. Diabetes Care. 1992;15:396–417
  5. Thorens B, Charron MJ, Lodish HF. Molecular physiology of glucose transporters. Diabetes Care. 1990;13:209–218
  6. James DE, Brown R, Navarro J, et al.  Insulin-regulatable tissues express a unique insulin sensitive glucose transport protein. Nature. 1988;333:183–185
  7. Garvey WT, Maianu L, Huecksteadt TP, et al.  Pretranslational suppression of GLUT4 glucose transporters causes insulin resistance in type II diabetes. J Clin Invest. 1991;87:1072–1081
  8. Sinha MK, Raineri-Maldonado C, Buchanan C, et al.  Adipose tissue glucose transporter in NIDDM: Decreased levels of muscle/fat isoform. Diabetes. 1991;40:472–477
  9. Handberg A, Vaag A, Damsbo P, et al.  Expression of insulin-regulatable glucose transporters in skeletal muscle from type 2 (non—insulin-dependent) diabetic patients. Diabetologia. 1990;33:625–627
  10. Eriksson J, Koranyi L, Bourey R, et al.  Insulin resistance in type 2 (non—insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT4) gene in human skeletal muscle. Diabetologia. 1992;35:143–147
  11. Garvey WT, Maianu L, Hancock JA, et al.  Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes. 1992;41:465–475
  12. Pedersen O, Bak JF, Andersen PH, et al.  Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes. 1990;39:865–870
  13. Gerich JE. Oral hypoglycemic agents. N Engl J Med. 1989;321:1231–1245
  14. Defronzo RA, Barzilai N, Simonsen DC. Mechanism of metformin action in obese and lean NIDD subjects. J Clin Endocrinol Metab. 1991;73:1294–1301
  15. Colca JR, Morton DR. Antihyperglycemic thiazoledinediones: Ciglitazone and its analogs. In:  Bailey CJ,  Flatt PR editor. New Antidiabetic Drugs. New York, NY: Smith-Gordon; 1990;p. 255–261
  16. Fujwara T, Yoshioka A, Yoshioka T, et al.  Characterization of a new oral antidiabetic agent CS-045: Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes. 1988;37:1549–1558
  17. Suter SL, Nolan JJ, Wallace P, et al.  Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care. 1993;15:193–203
  18. Sargent R, Mitsumoto Y, Sarabia V, et al.  Hormonal regulation of glucose transporters in muscle cells in culture. J Endocrinol Invest. 1993;16:147–162
  19. Yoshioka T, Fujita T, Kawai T, et al.  Thiazolidine derivatives with anti-diabetics activity, their preparation and their use. Chem Abstr. 1991;115:P183286h
  20. Klip A, Li G, Logan W. Induction of sugar uptake response to insulin by serum depletion in fusing L6 myoblasts. Am J Physiol. 1984;247:E291–E296
  21. Mitsumoto Y, Burdett E, Grant A, et al.  Differential expression of the GLUT1 and GLUT4 glucose transporters during differentiation of L6 muscle cells. Biochem Biophys Res Commun. 1991;652:652–659
  22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal Biochem. 1975;72:247–254
  23. Walker PS, Ramlal T, Sarabia V, et al.  Glucose transport activity in L6 muscle cells is regulated by the coordinate control of subcellular glucose transporter distribution, biosynthesis, and mRNA transcription. J Biol Chem. 1990;265:1516–1523
  24. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. In: ed 6. Proc Natl Acad Sci USA. 76:1979;p. 4350–4354
  25. Mitsumoto Y, Klip A. Developmental regulation of the subcellular distribution and glycosylation of GLUT1 and GLUT4 glucose transporters during myogenesis of L6 muscle cells. J Biol Chem. 1992;267:4957–4962
  26. Marette A, Burdett E, Douen A, et al.  Insulin induces the translocation of GLUT4 from a unique intracellular organelle to transverse tubules in rat skeletal muscle. Diabetes. 1992;41:1562–1569
  27. Hirshman MF, Goodyear LJ, Wardzala LJ, et al.  Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle. J Biol Chem. 1990;265:987–991
  28. Garcia de Herreros A, Birnbaum MJ. The acquisition of increased insulin-responsive hexose transport in 3T3-L1 adipocytes correlates with expression of a novel transporter gene. J Biol Chem. 1989;264:19994–19999
  29. Stevenson R, Hutson N, Krupp M, et al.  Actions of novel antidiahetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob mice. Diabetes. 1990;39:1218–1227
  30. Sandouk T, Reda D, Hofmann C. The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3F442A cells by increasing messenger ribonucleic acid transcript stability. Endocrinology. 1993;133:352–359
  31. E1-kebbi I, Roser S, Pollet RJ. Regulation of glucose transport by pioglitazone in cultured muscle cells. Metabolism. 1994;43:953–958
  32. Kletzien R, Clarke S, Ulrich R. Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol. 1991;41:393–398
  33. Weinstein SP, Holand A, O'Boyle E, et al.  Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle. Metabolism. 1993;42:1365–1369
  34. Shargill NS, Tatoyan A, Fukishima M, et al.  Effect of ciglitazone on glucose uptake and insulin sensitivity in skeletal muscle of the obese (ob/ob) mouse: Distinct insulin and glucocorticoid effects. Metabolism. 1986;35:64–70
  35. Hofmann C, Lorenz K, Colca JR. Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. Endocrinology. 1991;129:1915–1925
  36. Ciaraldi TP, Gilmore A, Olefsky JM, et al.  In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism. 1990;39:1056–1062

☆ Supported by funds from the Medical Research Service of the Veterans Administration, Grant No. DK-33649 from the National Institutes of Health, and a grant from Sankyo.

PII: 0026-0495(95)90092-6

Metabolism - Clinical and Experimental
Volume 44, Issue 8 , Pages 976-981 , August 1995

Article Tools